Johns Hopkins ABX Guide
Ceftazidime/avibactam
INDICATIONS
FDA
FDA
- Complicated intra-abdominal infection (cIAI) in combination with metronidazole
- Complicated urinary tract infection (cUTI) including pyelonephritis
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Resistant Gram-negative infections including ESBL-producing and certain carbapenemase-producing (KPC only) bacteria
- Trials are currently underway for the management of hospital-acquired and/or ventilator-associated pneumonia
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: November 7, 2019
Citation
Dzintars, Kathryn. "Ceftazidime/avibactam." Johns Hopkins ABX Guide, The Johns Hopkins University, 2019. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540652/5.3/Ceftazidime_avibactam.
Dzintars K. Ceftazidime/avibactam. Johns Hopkins ABX Guide. The Johns Hopkins University; 2019. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540652/5.3/Ceftazidime_avibactam. Accessed December 27, 2024.
Dzintars, K. (2019). Ceftazidime/avibactam. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540652/5.3/Ceftazidime_avibactam
Dzintars K. Ceftazidime/avibactam [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2019. [cited 2024 December 27]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540652/5.3/Ceftazidime_avibactam.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Ceftazidime/avibactam
ID - 540652
A1 - Dzintars,Kathryn,Pharm.D. BCPS
Y1 - 2019/11/07/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540652/5.3/Ceftazidime_avibactam
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
